Sema4 President and COO James Coffin to take 90-day medical leave; CFO and CBO to assume duties

GeneDx Holdings Corp.

James Coffin, President and COO, expects 90-day disability leave starting October 2021.
CFO Isaac Ro and Chief Business Officer Kareem Saad will perform Coffin's functions during leave.
Company does not anticipate adverse impact on financial performance or corporate objectives.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

James Coffin

President and Chief Operating Officer

WGS · GeneDx Holdings Corp.

Effective: 2021-10
Filed: October 14, 2021, 7:59 PM ET

James Coffin, Ph.D. the Company’s Treasurer from January 2021 to March 2021, and President and Chief Operating Officer since 2017, expects to be on short-term disability leave for medical reasons for approximately 90 days, commencing sometime in October 2021 (the “Leave”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

James Coffin changed role as President and Chief Operating Officer at GeneDx Holdings Corp..

Action: Taking 90-day medical leave
Role: President and Chief Operating Officer

Exact text from the filing

James Coffin, Ph.D. the Company’s Treasurer from January 2021 to March 2021, and President and Chief Operating Officer since 2017, expects to be on short-term disability leave for medical reasons for approximately 90 days, commencing sometime in October 2021 (the “Leave”).

View on SEC.gov

GeneDx Holdings Corp. filing history →

Source: SEC EDGAR

accession 0001818331-21-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.